Dexamethasone in Prolonging the Duration of Spinal Anesthesia Among Pregnant Patients

NCT07088146 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-07-28

No results posted yet for this study

Summary

Lower segment C section is one of the most commonly performed surgeries worldwide. It is performed in spinal anesthesia. During Spinal Anesthesia a local anesthetic drug is administered in a space surrounding spinal cord and it blocks nerves originating from spinal cord providing both anesthesia and analgesia. This technique avoids harmful exposure of drugs to the baby inside the womb of mother. However this technique provides anesthesia and analgesia of limited duration which can be prolonged by addition of drugs to patient management regimen. One such drug is Dexamethasone which is a steroid commonly administered in the peri-operative period.

Conditions

  • Spinal Anesthesia
  • Post Operative Analgesia

Interventions

DRUG

Dexamethasone

Immediately after sub-arachnoid block 8mg of Dexamethasone will be administered intravenously

DRUG

Placebo

2ml of Normal saline will be given intravenously immediately after administration of spinal anesthesia

Sponsors & Collaborators

  • Rawalpindi Medical College

    lead OTHER

Principal Investigators

  • Abeera Zareen, MBBS,FCPS · Rawalpindi Medical College

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-20
Primary Completion
2025-10-20
Completion
2025-10-20
FDA Drug
Yes

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07088146 on ClinicalTrials.gov